跳至主要内容
临床试验/DRKS00003368
DRKS00003368已完成未知

Chlorhexidine containing IV-catheter securement dressings for the prevention of central venous catheter-related bloodstream infections in neutropenic patients: a prospective randomized trial - COAT

1st Department of Internal MedicineCologne University Hospital0 个研究点目标入组 630 人开始时间: 2012年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
630

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Patients receiving a central venous catheter for chemotherapy of:
  • Patients receiving receiving a central venous catheter for:
  • o high-dose chemotherapy with consecutive autologous stem cell transplantation
  • o any other other condition with an expected duration of chemotherapy-associated neutropenia of at least 5 days and an expected duration of central venous catheter use of at least 10 days
  • Age =18 years

排除标准

  • Patients previously enrolled in the study
  • Tunneled central venous catheters
  • Shaldon catheters
  • CVC insertion via the V. femoralis
  • Fever (T >37.8°C) related to a suspected or confirmed bacterial infection at randomization
  • Known allergic/hypersensitivity reaction to any compounds of the treatment
  • Pregnant or breast-feeding
  • Legal incapacity or limited legal capacity
  • Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent

研究者

发起方
1st Department of Internal MedicineCologne University Hospital

相似试验